dactinomycin has been researched along with ginsenosides in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, SY; Kim, YN; Koo, KH; Lee, CH; Lee, JH; Ye, SK; Yun, UJ | 1 |
1 other study(ies) available for dactinomycin and ginsenosides
Article | Year |
---|---|
Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Death; Cell Line, Tumor; Cholesterol; Dactinomycin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Ginsenosides; Humans; Membrane Microdomains; Oncogene Protein pp60(v-src); Ovarian Neoplasms; Rhodamine 123; Signal Transduction | 2013 |